ITB-Med LLC
ITB-Med LLC
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Delayed Tolerance Through Mixed Chimerism | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-28 | NCT05900401 | |
| Tolerance Through Mixed Chimerism (Sip-Tego) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Early phase 1 | 2026-09-25 | NCT06972069 | |
| Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Early phase 1 | 2026-09-01 | NCT06326476 | |
| A Study of SIPLIZUMAB in AILD and LT Patients | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, chronic liver failure, cirrhosis of liver, hepatitis, immune system disorder, liver disorder, liver failure, primary sclerosing cholangitis | Recruiting | Phase 1 | 2025-11-24 | NCT06455280 | |
| A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation | Liver Transplantation | Active, not recruiting | Phase 2 | 2024-11-27 | NCT06019507 |